Cittadine Andrew 4
4 · Monopar Therapeutics · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Monopar (MNPR) COO Andrew Cittadine Receives 3,514 RSU Shares
What Happened
Andrew Cittadine, Chief Operating Officer of Monopar Therapeutics (MNPR), had restricted stock units (RSUs) vest and convert into 3,514 shares of common stock on March 31, 2026. The company withheld 1,571 of those shares to satisfy tax withholding obligations at $54.79/share (total withheld value $86,075), leaving a net of 1,943 shares added to his beneficial ownership. This was an RSU settlement (compensation), not an open‑market purchase.
Key Details
- Transaction date: March 31, 2026; Form 4 filed April 2, 2026 (timely filing).
- Lines reported:
- Code M (conversion of derivative): 3,514 shares acquired (RSU settlement) — no cash price.
- Code F (payment of tax liability): 1,571 shares withheld/disposed at $54.79 each = $86,075.
- Code M (disposition of derivative): 3,514 RSUs surrendered/converted (reported at $0.00).
- Net shares added to beneficial ownership from this event: 1,943 shares (3,514 acquired − 1,571 withheld).
- Shares owned after transaction: not disclosed in the provided excerpt of the filing.
- Relevant footnotes: RSU grants described (Feb 1, 2023 and Mar 4, 2025 grants with multi‑year vesting schedules); withheld shares used to pay applicable withholding taxes.
- No indication of a 10b5‑1 plan; this was routine compensation vesting rather than a market purchase or sale.
Context
This was a routine vesting/settlement of RSUs (a derivative converting into common stock). The shares withheld to cover taxes are a standard cashless/withholding settlement and do not by themselves indicate a buy or sell sentiment. The filing appears timely (filed within the required two business days).
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-03-31+3,514→ 54,240 total - Tax Payment
Common Stock
[F2]2026-03-31$54.79/sh−1,571$86,075→ 52,669 total - Exercise/Conversion
Restricted Stock Unit
[F1][F3][F4]2026-03-31−3,514→ 44,753 total→ Common Stock (3,514 underlying)
Footnotes (4)
- [F1]Represents shares acquired on vesting and settlement of restricted stock units.
- [F2]Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
- [F3]On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- [F4]On March 4, 2025, the reporting person was granted 40,581 restricted stock units, vesting 6/48ths (5,073 shares) on June 30, 2025, and 3/48ths (2,536 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.